Hepatitis Physiopathology
Mostrando 1-7 de 7 artigos, teses e dissertações.
-
1. Acquired hepatocerebral degeneration in a patient with hepatitis B and hepatitis delta virus coinfection
Abstract Acquired hepatocerebral degeneration is a neurological syndrome with typical clinical (extrapyramidal and neuropsychiatric) symptoms and brain magnetic resonance imaging findings (high T1 signal in the globus pallidus). It occurs mainly in patients with advanced liver disease, such as in patients co-infected with hepatitis B virus (HBV) and hepatiti
Rev. Soc. Bras. Med. Trop.. Publicado em: 2017-06
-
2. Fulminant hepatitis failure in adults and children from a Public Hospital in Rio de Janeiro, Brazil
Fulminant hepatic failure (FHF) is characterized by massive hepatocellular injury, whose physiopathology is still unclear. Hepatitis B (HBV) is probably the most common viral cause of FHF, while hepatitis A (HAV) virus seem occurs less frequently. However, the host and viral factors that determine the outcome of these infections are poorly understood. In the
Brazilian Journal of Infectious Diseases. Publicado em: 2009-10
-
3. Hepatitis C and cytokines - study in blood and liver / Hepatite C crônica e citocinas - estudo no soro e no fígado
INTRODUÇÃO: A patogênese da hepatite C crônica resulta principalmente de mecanismos imuno-mediados com a atuação central das citocinas tanto na lesão hepatocelular como na eliminação e na persistência do vírus da hepatite C (VHC). OBJETIVOS: Investigar a resposta imune adaptativa da hepatite C crônica através da expressão das células inflamat�
Publicado em: 2007
-
4. Porphyria cutanea tarda. Evolution study of the clinical and laboratory features: biochemistry, immunofluorescence and light microscopy / "Porfiria cutânea tardia. Estudo evolutivo das características clínicas e laboratoriais: bioquímica, imunofluorescência e microscopia óptica"
Porphyria cutanea tarda is caused by the inherited or acquired partial deficiency of the uroporphyrinogen decarboxylase enzyme activity, resulting in the accumulation of uroporphyrin and hepta-carboxyl porphyrinogen in the liver. The purpose of this study was to investigate the clinical and laboratory features: biochemistry and the alterations on skin morpho
Publicado em: 2006
-
5. "Hepatite colestática associada ao vírus da hepatite C pós-transplante hepático: estudo virológico, histopatológico e imuno-histoquímico" / Severe recurrent cholestatic hepatitis after liver transplantation : virological, histological and immuno-histochemical evaluation
Following liver transplantation (OLT) HCV-related disease severity is highly variable, with a minority of cases progressing to an extremely severe form of cholestatic hepatitis, in which the pathogenesis is not yet understood. We aim to compare virological, histological and immunohistological changes in patients developing mild and severe post-OLT HCV recurr
Publicado em: 2004
-
6. Esteato-hepatite não alcoólica: avaliação clínica, laboratorial, histopatológica e pesquisa de mutações do gene HFE: casuística de um centro de referência / Non-alcoholic steatohepatitis: clinical, laboratory, histopathologic evaluation and search for mutations in the HFE gene: casuistic from a reference center.
Non-alcoholic steatohepatitis (NASH) consists of steatosis and hepatic lobular inflammation in non-alcoholic individuals. It occurs in association to obesity, hyperlipidemia, diabetes mellitus, female sex, drug therapy and jejunoileal bypass. Recently, iron overload, secondary to mutations in the HFE gene in hereditary hemochromatosis has also been evidenced
Publicado em: 2000
-
7. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.
Sequencing of multiple recombinant clones generated from polymerase chain reaction-amplified products demonstrated that the degree of heterogeneity of two well-conserved regions of the hepatitis C virus (HCV) genome within individual plasma samples from a single patient was consistent with a quasispecies structure of HCV genomic RNA. About half of circulatin